Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

30 56 30 30 13 4 7 15 13 20 25 12 35 13 2

Research, Review articles and Editorials

0 6 2 4 1 1 6 14 12 17 25 12 34 7 2

Research communications, Review communications, Editorial communications, Case reports and Commentary

30 50 28 8 2 0 1 1 1 2 0 0 0 0 0

Conference proceedings

0 0 0 0 0 0 35 102 83 47 82 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

35 55 58 71 61 49 63 48 72 63 23 8 6 0 0
Journal total citations count 613
Journal impact factor 2.31
Journal 5 years impact factor 3.74
Journal cite score 4.86
Journal h-index 12
Important citations

Redox Biology of Respiratory Viral Infections.

Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates

SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics

Low uric acid level increases the risk of infectious mononucleosis and this effect is more pronounced in women

OXIDATIVE STRESS AND CYTOKINES’ INVOLVEMENT IN THE OCCURENCE AND PROGRESSION OF DIABETIC COMPLICATIONS IN THE COVID-19 PANDEMIC CONTEXT

Low uric acid level increases the risk of infectious mononucleosis and this effect is more pronounced in women

Oxidative stress and inflammatory biomarkers for the prediction of severity and ICU admission in unselected patients hospitalized with COVID-19

Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19

The central role of mitochondrial fitness on antiviral defenses: An advocacy for physical activity during the COVID-19 pandemic

Should we unstress SARS-CoV-2 infected cells?

NOX-dependent signaling dysregulation in severe COVID-19: clues to effective treatments

COVID-19: Oxidative Preconditioning as a Potential Therapeutic Approach

The pneumococcal two-component system SirRH is linked to enhanced intracellular survival of Streptococcus pneumoniae in influenza-infected pulmonary cells

Oxidative stress markers in infectious respiratory diseases: current clinical practice

Phenotypical characterization of human rhinovirus infections in severely premature children

Morning sickness in pregnancy: mini review of possible causes with proposal for monitoring by diagnostic methods

Odoriferous therapy: a review identifying essential oils against pathogens of the respiratory tract

Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications

Suppression of nuclear factor erythroid?2?related factor 2?mediated antioxidative defense in the lung injury induced by chronic exposure to methamphetamine in rats

Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities